Ken Griffin Bio Rad Laboratories, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $1.4 Million - $1.83 Million	-5,300 Reduced 73.61%	1,900 $635,000
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $1.18 Million - $1.49 Million	-4,400 Reduced 37.93%	7,200 $1.97 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $2.43 Million - $2.82 Million	-8,000 Reduced 40.82%	11,600 $4.01 Million
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $1.62 Million - $2.19 Million	-6,000 Reduced 23.44%	19,600 $6.33 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $2.98 Million - $3.59 Million	8,500 Added 49.71%	25,600 $9.18 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $2.88 Million - $3.89 Million	8,000 Added 87.91%	17,100 $6.48 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $15.2 Million - $18.3 Million	-36,300 Reduced 79.96%	9,100 $4.36 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $9.57 Million - $12.4 Million	-27,200 Reduced 37.47%	45,400 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $3.75 Million - $5.13 Million	9,100 Added 14.33%	72,600 $30.3 Million

456

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.14B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.